Kristyn Masters
Concepts (340)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcinosis | 15 | 2022 | 234 | 4.700 |
Why?
| | Aortic Valve | 17 | 2022 | 365 | 4.330 |
Why?
| | Extracellular Matrix | 21 | 2025 | 553 | 3.230 |
Why?
| | Aortic Valve Stenosis | 7 | 2022 | 253 | 2.940 |
Why?
| | Tissue Engineering | 13 | 2021 | 442 | 2.890 |
Why?
| | Biocompatible Materials | 15 | 2018 | 435 | 2.100 |
Why?
| | Heart Valve Diseases | 7 | 2017 | 151 | 1.800 |
Why?
| | Hyaluronic Acid | 7 | 2013 | 208 | 1.690 |
Why?
| | Polyurethanes | 5 | 2013 | 38 | 1.660 |
Why?
| | Epidermal Growth Factor | 6 | 2016 | 171 | 1.600 |
Why?
| | Keratinocytes | 6 | 2016 | 248 | 1.580 |
Why?
| | Nylons | 8 | 2014 | 23 | 1.570 |
Why?
| | Cell Culture Techniques | 8 | 2019 | 375 | 1.250 |
Why?
| | Swine | 18 | 2017 | 833 | 1.200 |
Why?
| | Collagen | 8 | 2025 | 456 | 1.160 |
Why?
| | Immobilized Proteins | 3 | 2016 | 10 | 1.140 |
Why?
| | Myofibroblasts | 3 | 2017 | 143 | 1.100 |
Why?
| | Cell Adhesion | 15 | 2025 | 455 | 1.070 |
Why?
| | Cell Movement | 11 | 2019 | 965 | 1.060 |
Why?
| | Heart Valves | 5 | 2010 | 43 | 0.940 |
Why?
| | Cell Proliferation | 15 | 2017 | 2496 | 0.920 |
Why?
| | Endothelial Cells | 5 | 2017 | 869 | 0.920 |
Why?
| | Cells, Cultured | 21 | 2022 | 4154 | 0.920 |
Why?
| | Wound Healing | 6 | 2016 | 351 | 0.820 |
Why?
| | Fibroblasts | 8 | 2013 | 1034 | 0.760 |
Why?
| | Fibronectins | 5 | 2021 | 136 | 0.700 |
Why?
| | Gelatin | 3 | 2025 | 56 | 0.690 |
Why?
| | Osteoblasts | 2 | 2012 | 145 | 0.670 |
Why?
| | Simvastatin | 2 | 2012 | 60 | 0.650 |
Why?
| | Surface Properties | 11 | 2013 | 410 | 0.600 |
Why?
| | Animals | 36 | 2021 | 38058 | 0.580 |
Why?
| | Laminin | 3 | 2015 | 72 | 0.580 |
Why?
| | Gene Expression Regulation | 7 | 2017 | 2608 | 0.560 |
Why?
| | Fibrosis | 2 | 2022 | 548 | 0.550 |
Why?
| | Contracts | 1 | 2017 | 11 | 0.530 |
Why?
| | Cell Communication | 4 | 2018 | 324 | 0.530 |
Why?
| | Mentors | 2 | 2017 | 219 | 0.530 |
Why?
| | NIH 3T3 Cells | 9 | 2014 | 148 | 0.520 |
Why?
| | Phospholipase C gamma | 2 | 2019 | 28 | 0.520 |
Why?
| | Methacrylates | 1 | 2017 | 119 | 0.490 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2012 | 439 | 0.490 |
Why?
| | Science | 1 | 2017 | 56 | 0.490 |
Why?
| | Actins | 4 | 2012 | 425 | 0.480 |
Why?
| | Signal Transduction | 5 | 2018 | 5226 | 0.470 |
Why?
| | Atherosclerosis | 1 | 2019 | 409 | 0.460 |
Why?
| | Documentation | 1 | 2017 | 198 | 0.450 |
Why?
| | Hyperlipoproteinemia Type II | 1 | 2015 | 32 | 0.450 |
Why?
| | Tissue Scaffolds | 4 | 2021 | 223 | 0.450 |
Why?
| | Muscle Proteins | 1 | 2017 | 244 | 0.450 |
Why?
| | Osteocalcin | 2 | 2012 | 38 | 0.440 |
Why?
| | Interprofessional Relations | 1 | 2017 | 281 | 0.440 |
Why?
| | Polymers | 6 | 2015 | 499 | 0.430 |
Why?
| | Pluripotent Stem Cells | 1 | 2015 | 84 | 0.420 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2018 | 381 | 0.420 |
Why?
| | Nitric Oxide Donors | 2 | 2005 | 20 | 0.410 |
Why?
| | Intracranial Aneurysm | 1 | 2014 | 103 | 0.390 |
Why?
| | Apoptosis | 8 | 2017 | 2430 | 0.380 |
Why?
| | Materials Testing | 6 | 2017 | 354 | 0.380 |
Why?
| | Extracellular Matrix Proteins | 2 | 2014 | 158 | 0.370 |
Why?
| | Ovarian Neoplasms | 3 | 2025 | 586 | 0.370 |
Why?
| | Molecular Structure | 8 | 2014 | 499 | 0.370 |
Why?
| | RNA | 2 | 2017 | 940 | 0.370 |
Why?
| | Communication | 2 | 2023 | 965 | 0.360 |
Why?
| | Adsorption | 4 | 2013 | 157 | 0.360 |
Why?
| | Computer Simulation | 2 | 2018 | 1025 | 0.360 |
Why?
| | Cell Differentiation | 9 | 2018 | 2050 | 0.350 |
Why?
| | Fallopian Tubes | 2 | 2022 | 33 | 0.350 |
Why?
| | Embolization, Therapeutic | 1 | 2014 | 242 | 0.350 |
Why?
| | Dermatan Sulfate | 1 | 2010 | 4 | 0.330 |
Why?
| | Macrophages | 3 | 2015 | 1511 | 0.330 |
Why?
| | Biofouling | 1 | 2010 | 8 | 0.330 |
Why?
| | Cystadenocarcinoma, Serous | 2 | 2022 | 84 | 0.330 |
Why?
| | Peptides | 4 | 2014 | 995 | 0.320 |
Why?
| | rho GTP-Binding Proteins | 1 | 2010 | 56 | 0.320 |
Why?
| | Gene Expression | 2 | 2012 | 1490 | 0.310 |
Why?
| | Tissue Culture Techniques | 3 | 2017 | 83 | 0.310 |
Why?
| | Integrins | 1 | 2010 | 89 | 0.310 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 318 | 0.310 |
Why?
| | Phenotype | 7 | 2021 | 3162 | 0.310 |
Why?
| | Candida albicans | 3 | 2015 | 61 | 0.310 |
Why?
| | Hydrogels | 7 | 2019 | 700 | 0.300 |
Why?
| | Algorithms | 1 | 2017 | 1837 | 0.300 |
Why?
| | Adipogenesis | 1 | 2009 | 57 | 0.300 |
Why?
| | Regeneration | 1 | 2011 | 197 | 0.290 |
Why?
| | Biomimetic Materials | 1 | 2009 | 76 | 0.290 |
Why?
| | Biomarkers | 7 | 2021 | 4271 | 0.290 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 138 | 0.280 |
Why?
| | Research Personnel | 2 | 2021 | 186 | 0.280 |
Why?
| | Stem Cells | 2 | 2011 | 626 | 0.280 |
Why?
| | Flow Cytometry | 3 | 2021 | 1173 | 0.280 |
Why?
| | Cell Line | 5 | 2017 | 2882 | 0.280 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 175 | 0.280 |
Why?
| | Adipocytes | 1 | 2009 | 223 | 0.270 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2008 | 178 | 0.260 |
Why?
| | MAP Kinase Signaling System | 1 | 2009 | 310 | 0.250 |
Why?
| | Humans | 33 | 2025 | 144759 | 0.250 |
Why?
| | Heart Valve Prosthesis | 2 | 2005 | 134 | 0.250 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2008 | 319 | 0.240 |
Why?
| | Amino Acids | 1 | 2009 | 521 | 0.230 |
Why?
| | Molecular Weight | 3 | 2013 | 327 | 0.230 |
Why?
| | Mice | 13 | 2020 | 18339 | 0.230 |
Why?
| | Cell Survival | 5 | 2017 | 1098 | 0.230 |
Why?
| | S-Nitrosothiols | 1 | 2005 | 5 | 0.220 |
Why?
| | Bioprosthesis | 1 | 2005 | 40 | 0.220 |
Why?
| | Tunica Intima | 1 | 2005 | 79 | 0.220 |
Why?
| | Antifungal Agents | 3 | 2015 | 149 | 0.210 |
Why?
| | Biomedical Engineering | 2 | 2018 | 29 | 0.210 |
Why?
| | Cysteine | 1 | 2005 | 210 | 0.200 |
Why?
| | Mass Behavior | 1 | 2023 | 4 | 0.200 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 851 | 0.190 |
Why?
| | Gelatinases | 1 | 2022 | 6 | 0.190 |
Why?
| | Ligands | 2 | 2018 | 673 | 0.180 |
Why?
| | Time Factors | 5 | 2015 | 7173 | 0.180 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 983 | 0.180 |
Why?
| | Culture Media, Serum-Free | 3 | 2012 | 42 | 0.180 |
Why?
| | Fallopian Tube Neoplasms | 1 | 2022 | 19 | 0.180 |
Why?
| | Matrix Metalloproteinases | 1 | 2022 | 98 | 0.180 |
Why?
| | Carcinoma in Situ | 1 | 2022 | 44 | 0.180 |
Why?
| | Bacterial Adhesion | 2 | 2013 | 109 | 0.170 |
Why?
| | Pressure Ulcer | 1 | 2022 | 43 | 0.170 |
Why?
| | Cytokines | 3 | 2021 | 2061 | 0.170 |
Why?
| | Staining and Labeling | 1 | 2022 | 151 | 0.170 |
Why?
| | Monitoring, Immunologic | 1 | 2021 | 23 | 0.170 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2014 | 2027 | 0.170 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2002 | 198 | 0.170 |
Why?
| | Financial Management | 1 | 2021 | 16 | 0.170 |
Why?
| | Cell Count | 2 | 2013 | 320 | 0.160 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 3 | 2009 | 79 | 0.160 |
Why?
| | Women | 1 | 2020 | 50 | 0.160 |
Why?
| | Culture Media | 2 | 2017 | 161 | 0.160 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1716 | 0.160 |
Why?
| | Cattle | 3 | 2013 | 1000 | 0.150 |
Why?
| | Nitric Oxide | 1 | 2005 | 897 | 0.150 |
Why?
| | Immunophenotyping | 1 | 2021 | 322 | 0.150 |
Why?
| | Azides | 2 | 2011 | 47 | 0.150 |
Why?
| | Oropharyngeal Neoplasms | 1 | 2020 | 55 | 0.150 |
Why?
| | Papillomaviridae | 1 | 2020 | 115 | 0.150 |
Why?
| | Nasal Mucosa | 1 | 2020 | 112 | 0.150 |
Why?
| | rho-Associated Kinases | 2 | 2010 | 83 | 0.150 |
Why?
| | Nurses | 1 | 2022 | 178 | 0.150 |
Why?
| | Solubility | 2 | 2010 | 242 | 0.150 |
Why?
| | Microfluidics | 2 | 2018 | 62 | 0.140 |
Why?
| | Shock, Septic | 1 | 2021 | 216 | 0.140 |
Why?
| | Workload | 1 | 2020 | 170 | 0.140 |
Why?
| | Microfilament Proteins | 1 | 2019 | 135 | 0.140 |
Why?
| | Platelet Adhesiveness | 2 | 2010 | 15 | 0.140 |
Why?
| | Leukocytes, Mononuclear | 1 | 2021 | 573 | 0.140 |
Why?
| | Antigens, CD | 1 | 2021 | 555 | 0.130 |
Why?
| | Cations | 2 | 2014 | 82 | 0.130 |
Why?
| | Disease Models, Animal | 3 | 2020 | 4557 | 0.130 |
Why?
| | Glycosaminoglycans | 1 | 2017 | 74 | 0.130 |
Why?
| | Interferon-gamma | 1 | 2021 | 784 | 0.130 |
Why?
| | Skin | 1 | 2002 | 755 | 0.130 |
Why?
| | Lipopolysaccharides | 1 | 2021 | 863 | 0.130 |
Why?
| | Biomedical Research | 2 | 2021 | 710 | 0.130 |
Why?
| | Lipoproteins, LDL | 1 | 2017 | 119 | 0.130 |
Why?
| | Proteins | 2 | 2013 | 1021 | 0.130 |
Why?
| | Cell Line, Tumor | 3 | 2025 | 3540 | 0.130 |
Why?
| | Pressure | 1 | 2018 | 225 | 0.130 |
Why?
| | Elastic Modulus | 1 | 2017 | 121 | 0.130 |
Why?
| | Sex Characteristics | 1 | 2022 | 790 | 0.120 |
Why?
| | Least-Squares Analysis | 2 | 2016 | 76 | 0.120 |
Why?
| | DNA | 3 | 2013 | 1463 | 0.120 |
Why?
| | Cross-Linking Reagents | 2 | 2008 | 207 | 0.120 |
Why?
| | Molecular Probes | 1 | 2016 | 33 | 0.120 |
Why?
| | Cholesterol, LDL | 1 | 2017 | 358 | 0.120 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2016 | 128 | 0.120 |
Why?
| | Papillomavirus Infections | 1 | 2020 | 345 | 0.120 |
Why?
| | Light | 3 | 2010 | 411 | 0.110 |
Why?
| | Recombinant Proteins | 2 | 2009 | 1370 | 0.110 |
Why?
| | Cellular Microenvironment | 1 | 2016 | 94 | 0.110 |
Why?
| | Female | 9 | 2025 | 78271 | 0.110 |
Why?
| | Embryoid Bodies | 1 | 2014 | 8 | 0.110 |
Why?
| | Plaque, Atherosclerotic | 1 | 2015 | 60 | 0.110 |
Why?
| | Bacillus cereus | 1 | 2014 | 5 | 0.110 |
Why?
| | Drug Resistance, Fungal | 1 | 2014 | 7 | 0.110 |
Why?
| | Antigens | 2 | 2006 | 347 | 0.100 |
Why?
| | Cerebral Angiography | 1 | 2014 | 119 | 0.100 |
Why?
| | Biomechanical Phenomena | 1 | 2017 | 842 | 0.100 |
Why?
| | DNA Replication | 2 | 2014 | 251 | 0.100 |
Why?
| | Embryonic Stem Cells | 1 | 2014 | 130 | 0.100 |
Why?
| | Antibodies | 2 | 2006 | 401 | 0.100 |
Why?
| | Cholesterol | 1 | 2015 | 406 | 0.100 |
Why?
| | Acrylates | 2 | 2011 | 48 | 0.100 |
Why?
| | Salmonella enterica | 1 | 2014 | 59 | 0.100 |
Why?
| | Stress, Mechanical | 3 | 2010 | 494 | 0.100 |
Why?
| | U937 Cells | 1 | 2013 | 27 | 0.100 |
Why?
| | Gene Transfer Techniques | 1 | 2014 | 185 | 0.100 |
Why?
| | Erythrocytes | 2 | 2010 | 757 | 0.100 |
Why?
| | Dogs | 1 | 2014 | 437 | 0.090 |
Why?
| | Tumor Microenvironment | 1 | 2017 | 732 | 0.090 |
Why?
| | Anti-Bacterial Agents | 2 | 2014 | 1907 | 0.090 |
Why?
| | Vitronectin | 1 | 2012 | 7 | 0.090 |
Why?
| | Transfection | 1 | 2014 | 940 | 0.090 |
Why?
| | Mechanical Phenomena | 1 | 2013 | 80 | 0.090 |
Why?
| | ErbB Receptors | 2 | 2019 | 627 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 635 | 0.090 |
Why?
| | Biofilms | 1 | 2015 | 278 | 0.090 |
Why?
| | beta-Lactams | 1 | 2012 | 32 | 0.090 |
Why?
| | Alkaline Phosphatase | 1 | 2012 | 145 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1694 | 0.090 |
Why?
| | Primary Cell Culture | 1 | 2012 | 173 | 0.090 |
Why?
| | Oxidation-Reduction | 1 | 2015 | 1087 | 0.090 |
Why?
| | Microscopy, Fluorescence | 2 | 2010 | 416 | 0.090 |
Why?
| | Hemodynamics | 1 | 2017 | 1121 | 0.090 |
Why?
| | Genetic Markers | 1 | 2012 | 331 | 0.090 |
Why?
| | Carbodiimides | 1 | 2011 | 2 | 0.090 |
Why?
| | Models, Biological | 2 | 2016 | 1821 | 0.090 |
Why?
| | Dermis | 1 | 2011 | 32 | 0.080 |
Why?
| | Pseudomonas aeruginosa | 1 | 2014 | 356 | 0.080 |
Why?
| | Amines | 1 | 2011 | 39 | 0.080 |
Why?
| | Stimulation, Chemical | 1 | 2010 | 53 | 0.080 |
Why?
| | Chromatography, Gel | 1 | 2010 | 131 | 0.080 |
Why?
| | Receptors, Laminin | 1 | 2010 | 2 | 0.080 |
Why?
| | Glycols | 1 | 2010 | 5 | 0.080 |
Why?
| | Integrin alpha5beta1 | 1 | 2010 | 9 | 0.080 |
Why?
| | Osteogenesis | 1 | 2012 | 208 | 0.080 |
Why?
| | Aging | 1 | 2021 | 1966 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2012 | 758 | 0.080 |
Why?
| | Hyaluronan Receptors | 1 | 2010 | 102 | 0.080 |
Why?
| | Blood Proteins | 1 | 2012 | 249 | 0.080 |
Why?
| | Adhesiveness | 1 | 2009 | 18 | 0.080 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2010 | 81 | 0.080 |
Why?
| | Neovascularization, Physiologic | 1 | 2011 | 194 | 0.080 |
Why?
| | Polyethylene Glycols | 3 | 2009 | 654 | 0.070 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 173 | 0.070 |
Why?
| | Butadienes | 1 | 2009 | 37 | 0.070 |
Why?
| | MAP Kinase Kinase 2 | 1 | 2009 | 29 | 0.070 |
Why?
| | Cell Separation | 1 | 2010 | 307 | 0.070 |
Why?
| | Oligosaccharides | 1 | 2009 | 60 | 0.070 |
Why?
| | Mevalonic Acid | 1 | 2008 | 12 | 0.070 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2009 | 71 | 0.070 |
Why?
| | Mechanotransduction, Cellular | 1 | 2010 | 122 | 0.070 |
Why?
| | Succinimides | 1 | 2008 | 21 | 0.070 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 153 | 0.070 |
Why?
| | Rhodamines | 1 | 2008 | 21 | 0.070 |
Why?
| | Polystyrenes | 1 | 2008 | 37 | 0.070 |
Why?
| | Flavonoids | 1 | 2009 | 87 | 0.070 |
Why?
| | Thermodynamics | 1 | 2010 | 426 | 0.070 |
Why?
| | Cell Line, Transformed | 1 | 2008 | 140 | 0.070 |
Why?
| | Gels | 1 | 2008 | 84 | 0.070 |
Why?
| | Bone and Bones | 1 | 2011 | 314 | 0.070 |
Why?
| | Structure-Activity Relationship | 3 | 2014 | 570 | 0.070 |
Why?
| | Microbial Sensitivity Tests | 3 | 2014 | 370 | 0.070 |
Why?
| | Age Factors | 1 | 2015 | 3333 | 0.070 |
Why?
| | Fibrin | 1 | 2008 | 91 | 0.070 |
Why?
| | Male | 4 | 2022 | 72315 | 0.070 |
Why?
| | Nitriles | 1 | 2009 | 205 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2010 | 436 | 0.070 |
Why?
| | Drug Synergism | 1 | 2008 | 357 | 0.070 |
Why?
| | Disease Progression | 1 | 2015 | 2847 | 0.070 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2007 | 88 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2875 | 0.070 |
Why?
| | Reproducibility of Results | 2 | 2022 | 3409 | 0.060 |
Why?
| | Fluorescent Dyes | 1 | 2008 | 329 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2019 | 2452 | 0.060 |
Why?
| | Bacteria | 1 | 2013 | 889 | 0.060 |
Why?
| | Sex Factors | 1 | 2012 | 2112 | 0.060 |
Why?
| | Phosphorylation | 1 | 2010 | 1732 | 0.060 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 824 | 0.060 |
Why?
| | Curriculum | 1 | 2012 | 1059 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2012 | 1782 | 0.060 |
Why?
| | Compressive Strength | 1 | 2005 | 72 | 0.060 |
Why?
| | Elastin | 1 | 2005 | 79 | 0.050 |
Why?
| | Cyclic GMP | 1 | 2005 | 92 | 0.050 |
Why?
| | Stress Fibers | 1 | 2004 | 18 | 0.050 |
Why?
| | Protein Engineering | 1 | 2005 | 122 | 0.050 |
Why?
| | Elasticity | 1 | 2005 | 184 | 0.050 |
Why?
| | Indoles | 1 | 2008 | 501 | 0.050 |
Why?
| | Calcium | 1 | 2010 | 1183 | 0.050 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 2005 | 157 | 0.050 |
Why?
| | Blood Platelets | 1 | 2007 | 400 | 0.050 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2014 | 192 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2363 | 0.050 |
Why?
| | Carotid Arteries | 1 | 2005 | 207 | 0.050 |
Why?
| | Polyvinyl Alcohol | 1 | 2002 | 18 | 0.050 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2005 | 266 | 0.050 |
Why?
| | Occlusive Dressings | 1 | 2002 | 7 | 0.050 |
Why?
| | Polyvinyl Chloride | 1 | 2002 | 12 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2025 | 688 | 0.050 |
Why?
| | Versicans | 1 | 2021 | 5 | 0.050 |
Why?
| | Cicatrix | 1 | 2002 | 69 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 174 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2002 | 1047 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2021 | 140 | 0.040 |
Why?
| | HLA-DR Antigens | 1 | 2021 | 220 | 0.040 |
Why?
| | Oropharynx | 1 | 2020 | 46 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 184 | 0.040 |
Why?
| | Rats | 2 | 2005 | 5597 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 1 | 2005 | 2527 | 0.040 |
Why?
| | Spheroids, Cellular | 1 | 2019 | 73 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 336 | 0.030 |
Why?
| | Peer Group | 1 | 2020 | 257 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2019 | 508 | 0.030 |
Why?
| | Endoscopy | 1 | 2020 | 316 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2019 | 383 | 0.030 |
Why?
| | Biopsy | 1 | 2020 | 1075 | 0.030 |
Why?
| | Anesthesia | 1 | 2020 | 258 | 0.030 |
Why?
| | Cell Aggregation | 1 | 2016 | 19 | 0.030 |
Why?
| | Social Support | 1 | 2020 | 652 | 0.030 |
Why?
| | Photochemistry | 2 | 2006 | 134 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 2115 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 1195 | 0.030 |
Why?
| | Mothers | 1 | 2020 | 775 | 0.030 |
Why?
| | Models, Chemical | 2 | 2007 | 269 | 0.020 |
Why?
| | Clinical Competence | 1 | 2022 | 1244 | 0.020 |
Why?
| | Regression Analysis | 1 | 2016 | 1003 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2021 | 3604 | 0.020 |
Why?
| | 3T3 Cells | 1 | 2013 | 156 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2013 | 148 | 0.020 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2013 | 194 | 0.020 |
Why?
| | Behavior | 1 | 2012 | 91 | 0.020 |
Why?
| | Rheumatic Heart Disease | 1 | 2011 | 4 | 0.020 |
Why?
| | Cell Division | 2 | 2004 | 766 | 0.020 |
Why?
| | Awareness | 1 | 2012 | 108 | 0.020 |
Why?
| | Caregivers | 1 | 2020 | 1049 | 0.020 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2011 | 103 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2002 | 5992 | 0.020 |
Why?
| | Hemolysis | 1 | 2013 | 243 | 0.020 |
Why?
| | Personal Satisfaction | 1 | 2012 | 222 | 0.020 |
Why?
| | Shear Strength | 1 | 2010 | 72 | 0.020 |
Why?
| | Cell Size | 1 | 2010 | 92 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5868 | 0.020 |
Why?
| | Tensile Strength | 1 | 2010 | 96 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2010 | 128 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 7990 | 0.020 |
Why?
| | United States | 2 | 2021 | 15966 | 0.020 |
Why?
| | Equipment Design | 1 | 2010 | 530 | 0.020 |
Why?
| | Learning | 1 | 2012 | 452 | 0.020 |
Why?
| | Fluoresceins | 1 | 2007 | 48 | 0.020 |
Why?
| | Antigen-Antibody Reactions | 1 | 2006 | 50 | 0.020 |
Why?
| | Tetrazolium Salts | 1 | 2005 | 18 | 0.010 |
Why?
| | Thiazoles | 1 | 2005 | 135 | 0.010 |
Why?
| | Glucagon | 1 | 2005 | 112 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2005 | 321 | 0.010 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2002 | 18 | 0.010 |
Why?
| | Hydroxyproline | 1 | 2002 | 18 | 0.010 |
Why?
| | Kinetics | 1 | 2005 | 1627 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 1985 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2004 | 1257 | 0.010 |
Why?
|
|
Masters's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|